We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+4.96%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$11.8B
AUM Growth
+$5.07B
Cap. Flow
+$4.92B
Cap. Flow %
41.89%
Top 10 Hldgs %
13.22%
Holding
1,361
New
679
Increased
244
Reduced
170
Closed
248

Top Sells

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$74.7M
2
TSM icon
TSMC
TSM
+$65.2M
3
AZO icon
AutoZone
AZO
+$62.3M
4
BBY icon
Best Buy
BBY
+$56M
5
PM icon
Philip Morris
PM
+$54.1M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 23.25%
2 Healthcare 17.43%
3 Technology 12.56%
4 Financials 11.41%
5 Industrials 8.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPXC icon
751
SPX Corp
SPXC
$10.8B
$1.35M 0.01%
+40,639
New +$1.43M
BDC icon
752
Belden
BDC
$5.19B
$1.34M 0.01%
+18,819
New +$1.29M
BANF icon
753
BancFirst
BANF
$3.8B
$1.34M 0.01%
+22,405
New +$1.4M
ACLS icon
754
Axcelis
ACLS
$4.33B
$1.33M 0.01%
+67,852
New +$1.4M
FLIR
755
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
$1.33M 0.01%
+21,669
New +$1.28M
ANDX
756
DELISTED
Andeavor Logistics LP
ANDX
$1.32M 0.01%
27,209
+8,502
+45% +$399K
EPAC icon
757
Enerpac Tool Group
EPAC
$1.93B
$1.31M 0.01%
+46,815
New +$1.35M
BKR icon
758
Baker Hughes
BKR
$61.1B
$1.3M 0.01%
+38,579
New +$1.28M
OXFD
759
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$1.3M 0.01%
+80,435
New +$1.15M
ITRI icon
760
Itron
ITRI
$4.54B
$1.3M 0.01%
+20,255
New +$1.28M
SBBP
761
DELISTED
Strongbridge Biopharma plc.
SBBP
$1.29M 0.01%
+265,934
New +$1.36M
MSGS icon
762
Madison Square Garden
MSGS
$9.39B
$1.28M 0.01%
+5,696
New +$1.26M
RICK icon
763
RCI Hospitality Holdings
RICK
$215M
$1.27M 0.01%
+43,039
New +$1.37M
HLF icon
764
Herbalife
HLF
$1.29B
$1.27M 0.01%
+23,251
New +$1.28M
GSM icon
765
FerroAtlántica
GSM
$839M
$1.26M 0.01%
+153,949
New +$1.23M
IVC
766
DELISTED
Invacare Corporation
IVC
$1.26M 0.01%
+86,340
New +$1.43M
MPC icon
767
Marathon Petroleum
MPC
$83.7B
$1.25M 0.01%
+15,691
New +$1.24M
VRSN icon
768
VeriSign
VRSN
$26.6B
$1.24M 0.01%
+7,732
New +$1.18M
FISV
769
Fiserv Inc
FISV
$27.9B
$1.23M 0.01%
14,961
-2,333
-13% -$183K
MG icon
770
Mistras Group
MG
$512M
$1.23M 0.01%
+56,777
New +$1.23M
MTG icon
771
MGIC Investment
MTG
$6.25B
$1.21M 0.01%
91,157
UHS icon
772
Universal Health Services
UHS
$10.5B
$1.21M 0.01%
9,488
-71,869
-88% -$8.82M
LDL
773
DELISTED
Lydall, Inc.
LDL
$1.21M 0.01%
+28,132
New +$1.21M
NITE
774
DELISTED
Nightstar Therapeutics plc American Depositary Shares
NITE
$1.21M 0.01%
+58,996
New +$1.21M
RWGE.U
775
DELISTED
Regalwood Global Energy Ltd. Units, each consisting of one Class A ordinary share and one-third of o
RWGE.U
$1.2M 0.01%
1,200,000

Similar funds

Marshall Wace's Q3 2018 Portfolio in Review

As of Q3 2018, Marshall Wace held 1,361 positions worth $11.8B, up 76% from $6.68B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Marshall Wace deployed $4.92B of net new capital in Q3 2018, opening 679 new positions and adding to 244 existing holdings. Its largest new stake was Tractor Supply: 4,920,060 shares worth $89.4M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 23% of assets, up from 19% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Activision Blizzard, an estimated $74.7M trimmed.

  • Marshall Wace's largest Q3 2018 buy was Tractor Supply: 4,920,060 shares worth $89.4M.
  • Marshall Wace added most to Zoetis in Q3 2018, an estimated $124M increase.
  • Marshall Wace's biggest Q3 2018 reduction was Activision Blizzard, cutting an estimated $74.7M.
  • Marshall Wace fully exited AutoZone in Q3 2018, selling an estimated $62.3M.
  • Marshall Wace's ten largest holdings make up 13% of its $11.8B portfolio in Q3 2018.
  • Marshall Wace opened 679 new positions and closed 248 in Q3 2018.
  • Marshall Wace's portfolio value rose 76% quarter-over-quarter to $11.8B.

Based on Marshall Wace's 13F filing for Q3 2018, filed 14 Nov 2018.